• Nancy McGee

    Managing Director
    Manatt Health Solutions
    nmcgee@manatt.com
    Download Contact (.vcf)

    San Francisco
    Direct: 415.291.7402
    General: 415.291.7400
    Fax: 415.291.7474

    Education

    University of North Carolina, Gillings School of Global Public Health, Dr.P.H., 2011.

    Columbia University, Mailman School of Public Health, M.P.H., 2008.


    Hamline University, School of Law, J.D., 1995.


    University of California, Davis, B.A., English, 1991.

     

    • Profile
    • Representative Matters
    • Honors & Awards
    • Publications
    • Memberships & Activities
    • Speaking Engagements

    Profile

    Nancy McGee is a managing director of Manatt Health Solutions, an interdisciplinary policy and business advisory practice of Manatt, Phelps & Phillips, LLP.  With over 18 years of experience advising pharmaceutical, biotechnology and medical device companies, Dr. McGee is widely known for her expertise in reimbursement issues, particularly helping clients create effective coverage and payment strategies and developing new offerings designed to address payer and patient access issues.  She works with life sciences companies to identify opportunities and develop creative strategic and tactical approaches for specific products by analyzing healthcare policy, industry and distribution trends.

    Prior to joining Manatt, Dr. McGee was Senior Vice President and Chief Operating Officer for Lash Group (AmerisourceBergen Corporation).  In that role, she was an operational leader with P/L responsibility for an extensive portfolio of patient management programs and projects to help patients access new therapies.  She led over 100 pharmaceutical, biotechnology and medical device manufacturer-sponsored patient access programs representing several hundred products.

    Dr. McGee's project management and international consulting experience includes advising product manufacturers, payers, physician specialty societies and industry thought leaders across a range of coverage, payment, and distribution issues.  She leads specialized advisory boards for clients and conducts management and field force training sessions.  In addition, she designs specialized programs to assist physicians, patients and caregivers in navigating the complexities of the insurance industry.  Dr. McGee is a frequent lecturer on trends in healthcare legislation and the insurance industry in the United States and overseas.

    Before joining Lash Group, Dr. McGee was Vice President of Reimbursement for The Lewin Group, where she led both the reimbursement strategic consulting practice and the reimbursement support service lines.  She previously served as Director, Legal Affairs & Reimbursement at Somnus Medical Technologies, Inc., and as corporate counsel with VidaMed, Inc.

    Representative Matters

    Honors & Awards

    Publications

    Coauthor, “Five Megatrends Driving the Seismic Shift in Healthcare: How Should Pharma Respond to Succeed in a Transformed Market?” Manatt Health Solutions, July 2014.

    Coauthor, “Specialty Pharmaceuticals,” Health Affairs, November 25, 2013.

    Author, “Health Technology Assessment Evidence Criteria: What Types of Evidence Should Be Presented for Products Used to Screen for Disease in the United States?” Doctoral Dissertation, University of North Carolina, Chapel Hill, 2011.

    Lead author, “Private Health Plans Perspectives on Electronic Personal Health Records and Electronic Prescribing,” American Health & Drug Benefits, September/October 2009.

    Coauthor, “Developing Practices to Meet the Changing Business Paradigm,” Oncologistics Magazine, Third Quarter 2005.

    Memberships & Activities

    Member, Alumni Board, Columbia University’s Mailman School of Public Health.

    Representative-at-large, Gillings School of Global Public Health Alumni Association Governing Board, 2012 - present.

    Board member, Sustainable Kidney Care Foundation, 2011 - present.

    Speaking Engagements

    “Follow the Money: Data-Driven Methods for Tracking Drug Reimbursement Trends,” BIO International Convention, San Diego, CA, June 24, 2014.

     “Realities of the Affordable Care Act: Can Value be Legislated?” Health Spoken Here Conference, New York, NY, May 27, 2014.

     “How Pharmaceutical Manufacturers Are Planning for Coverage Expansion in 2014,” Health Policy and Management Healthcare Conference, Columbia University, Mailman School of Public Health, New York, New York, April 13, 2013.

     “Health Technology Assessment Evidence Criteria for Screening Products,” International Society for Pharmaeconomics and Outcomes Research (ISPOR) 15th Annual European Congress, Berlin, Germany, November 2012.
     

     “Adherence and Compliance Services in the U.S.,” GIRP: The European Association of Pharmaceutical Wholesalers Autumn Conference, Brussels, Belgium, November 2012.


     “Health Technology Assessment Evidence Criteria: What Types of Evidence Should Be Presented for Products Used to Screen for Disease in the United States?” Health Technology Assessment International (HTAi) Annual Meeting, Bilbao, Spain, June 25-27, 2012.


     “Health Care Reform and Its Impact on Patient Assistance Programs,” 7th Annual 340B Conference Sponsored by Safety Net Hospitals for Pharmaceutical Access, February 9, 2011. 


     “Patient Assistance Programs in the New Decade: Analysis and Best Practices for Pharmaceutical Manufacturers,” AmerisourceBergen Knowledge-Driven Webisode, March 17, 2010.


     “Developing U.S. Reimbursement Strategies for Conventional and Combination Medical Devices,” University of California, Berkeley, Extension Education Program, November 10, 2006.